NIR‐II Photoactivatable Cobalt(III) Nanoparticles for Photoactivated Metal Chemo‐Immunotherapy
Advanced Materials · 2026
DOI: 10.1002/adma.202516008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2026. Verfasst von Dongsheng Tang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Beijing National Laboratory for Molecular Sciences, Laboratory of Polymer Physics and Chemistry, Institute of Chemistry, Chinese Academy of Sciences,…. Hauptthemen laut MEDLINE: Cobalt, Infrared Rays, Immunotherapy, Metal Nanoparticles. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Natural Science Foundation of Beijing of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Photoactivated cobalt(III) (Co(III)) complexes have great potential for cancer therapy due to their unique interactions with cancer cells. However, its clinical application remains limited by its high toxicity due to low spatial‐temporal control. Here, a second near‐infrared window (NIR‐II) photoactivated Co(III) nanoparticles (NanoCo) is shown. Under 1064 nm light irradiation, NanoCo is capable of generating photothermal heat to accelerate the reduction of Co(III) to Co(II). Under hypoxic conditions, NanoCo is 166 times more effective than cisplatin at killing platinum‐resistant A549DDP tumor cells. Notably, when exposed to 1064 nm irradiation, NanoCo becomes 5000 times more effective than oxaliplatin at killing CT26 cells under normoxic conditions. NanoCo accumulates at the tumor site, generating photothermal heat and killing tumor cells under 1064 nm irradiation. Additionally, NanoCo under 1064 nm irradiation triggers immunogenic cell death, further stimulating dendritic cell maturation and inducing anti‐tumor immune responses. The combination of Pt(IV) nanoparticles (HSA@Pt) with NanoCo under 1064 nm irradiation achieves a 99% tumor growth inhibition rate in a 4T1 tumor‐bearing mouse model. This work is the first to introduce Co(III) complexes activated by NIR‐II light for photoactivated chemo‐immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing National Laboratory for Molecular Sciences, Laboratory of Polymer Physics and Chemistry, Institute of Chemistry, Chinese Academy of Sciences, Beijing, 100190, P. R. China.
- Faculty of Chemistry and Biochemistry, Ruhr-University, 44780, Bochum, Germany.
- Sydney Dental School, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, 2006, Australia.
- Charles Perkins Centre, The University of Sydney, Camperdown, NSW, 2006, Australia.
- Department of Nuclear Medicine, Peking University People's Hospital, Beijing, 100044, P. R. China.
- Department of Radiology, Peking University Third Hospital, Beijing, 100191, P. R. China.
ORCID-Profile: Haihua Xiao
Förderung
- Natural Science Foundation of Beijing of China
- National Natural Science Foundation of China
Zitieren
APA
Tang, D., Cui, M., Karges, J., Xu, C., Xiao, H., Shang, K., & Han, H. (2026). NIR‐II Photoactivatable Cobalt(III) Nanoparticles for Photoactivated Metal Chemo‐Immunotherapy. Advanced Materials. https://doi.org/10.1002/adma.202516008
Vancouver
Tang D, Cui M, Karges J, Xu C, Xiao H, Shang K, et al. NIR‐II Photoactivatable Cobalt(III) Nanoparticles for Photoactivated Metal Chemo‐Immunotherapy. Advanced Materials. 2026. doi:10.1002/adma.202516008
BibTeX
@article{Tang2026,
author = {Tang, Dongsheng and Cui, Minhui and Karges, Johannes and Xu, Chun and Xiao, Haihua and Shang, Kun and Han, Hongbin},
title = {NIR‐II Photoactivatable Cobalt(III) Nanoparticles for Photoactivated Metal Chemo‐Immunotherapy},
journal = {Advanced Materials},
year = {2026},
doi = {10.1002/adma.202516008}
}
EUVIMED